CS logo
small CS logo
Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière

Paris, Ile De France, France
Hôpital

About Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


L'hôpital de la Pitié-Salpêtrière est un hôpital de l'Assistance publique - Hôpitaux de Paris situé 47-83, boulevard de l'Hôpital dans le 13ᵉ arrondissement de Paris.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


During the past decade, Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


According to Clinical.Site data, the most researched conditions in "Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière" are "Arrhythmias, Cardiac" (1 trials), "Atrial Fibrillation and Flutter" (1 trials), "Cardiac Affections" (1 trials), "Cardiac Failure" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière" in a lesser frequency.

Clinical Trials Intervention Types at Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


Most popular intervention types in "Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Hormonal therapies L02 in the ATC classification" (1 trials), "Hormonal therapies: G03, H01C and L02 in the ATC classification" (1 trials) and "L02 (sex hormones used in treatment of neoplastic diseases) and G03 (sex hormones)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


The vast majority of trials in "Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière" are 2 trials for "Male" genders and 1 trials for "All" genders.

Clinical Trials Status at Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière


Currently, there are NaN active trials in "Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".